このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Genky DrugStores 将来の成長

Future 基準チェック /26

Genky DrugStores利益と収益がそれぞれ年間6.4%と6.8%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に12.1% 6.5%なると予測されています。

主要情報

6.7%

収益成長率

6.8%

EPS成長率

Consumer Retailing 収益成長	9.9%
収益成長率	6.8%
将来の株主資本利益率	12.2%
アナリストカバレッジ	Low
最終更新日	25 Jun 2024

今後の成長に関する最新情報

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Apr 27

Recent updates

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Apr 27

Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing

Mar 07

業績と収益の成長予測

TSE:9267 - アナリストの将来予測と過去の財務データ ( )JPY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2026	215,150	7,311	885	N/A	2
6/30/2025	200,133	6,723	-513	N/A	3
6/30/2024	184,767	6,082	1,642	N/A	3
3/20/2024	181,441	5,907	N/A	N/A	N/A
12/20/2023	177,152	5,580	-1,512	10,740	N/A
9/20/2023	173,317	5,106	N/A	N/A	N/A
6/20/2023	169,059	4,764	-1,155	8,773	N/A
3/20/2023	165,078	4,668	N/A	N/A	N/A
12/20/2022	162,272	4,559	-1,123	9,177	N/A
9/20/2022	158,134	4,290	N/A	N/A	N/A
6/20/2022	154,639	4,420	-4,431	6,076	N/A
3/20/2022	152,692	4,484	N/A	N/A	N/A
12/20/2021	149,500	4,527	-240	8,809	N/A
9/20/2021	146,419	4,775	N/A	N/A	N/A
6/20/2021	142,376	4,831	3,121	12,075	N/A
3/20/2021	140,851	4,449	N/A	N/A	N/A
12/20/2020	136,390	4,455	2,338	11,396	N/A
9/20/2020	130,173	3,565	N/A	N/A	N/A
6/20/2020	123,603	2,755	-3,594	7,411	N/A
3/20/2020	113,707	2,268	N/A	N/A	N/A
12/20/2019	108,305	1,958	-7,861	2,946	N/A
9/20/2019	105,832	2,334	N/A	N/A	N/A
6/20/2019	103,897	2,697	-6,422	4,300	N/A
3/20/2019	101,948	3,275	N/A	N/A	N/A
12/20/2018	100,167	3,179	-3,257	4,694	N/A
9/20/2018	97,753	3,178	N/A	N/A	N/A
6/20/2018	94,869	3,118	75	5,365	N/A
3/20/2018	92,031	2,972	N/A	N/A	N/A
12/20/2017	89,301	2,880	N/A	6,866	N/A
9/20/2017	86,379	2,867	N/A	N/A	N/A
6/20/2017	83,399	2,845	N/A	5,238	N/A
3/20/2017	80,879	2,603	N/A	N/A	N/A
12/20/2016	78,640	2,462	N/A	2,805	N/A
9/20/2016	76,170	2,223	N/A	N/A	N/A
6/20/2016	73,495	1,901	N/A	2,695	N/A
3/20/2016	70,426	1,643	N/A	N/A	N/A
12/20/2015	67,761	1,740	N/A	3,498	N/A
9/20/2015	65,413	1,743	N/A	N/A	N/A
6/20/2015	63,143	1,761	N/A	4,758	N/A
3/20/2015	61,524	1,819	N/A	N/A	N/A
12/20/2014	60,811	1,635	N/A	3,767	N/A
9/20/2014	59,853	1,452	N/A	N/A	N/A
6/20/2014	57,949	1,171	N/A	3,662	N/A
3/20/2014	56,365	944	N/A	N/A	N/A
12/20/2013	54,710	768	N/A	3,446	N/A
9/20/2013	53,502	630	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 9267の予測収益成長率 (年間6.4% ) は貯蓄率 ( 0.2% ) を上回っています。

収益対市場: 9267の収益 ( 6.4% ) JP市場 ( 8.9% ) よりも低い成長が予測されています。

高成長収益: 9267の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 9267の収益 ( 6.8% ) JP市場 ( 4.1% ) よりも速いペースで成長すると予測されています。

高い収益成長: 9267の収益 ( 6.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 9267の自己資本利益率は、3年後には低くなると予測されています ( 12.1 %)。

Genky DrugStores 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Consensus EPS estimates increase by 13%

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024

Price target increased by 9.3% to JP¥4,700

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending June 20, 2023 and Full Year Ending June 20, 2023

Recent updates

Upcoming dividend of JP¥13.00 per share

Genky DrugStores Co., Ltd. to Report Fiscal Year 2024 Results on Jul 29, 2024

Earnings Update: Here's Why Analysts Just Lifted Their Genky DrugStores Co., Ltd. (TSE:9267) Price Target To JP¥7,600

Third quarter 2024 earnings released: EPS: JP¥90.14 (vs JP¥68.63 in 3Q 2023)

Consensus EPS estimates increase by 13%

Return Trends At Genky DrugStores (TSE:9267) Aren't Appealing

Genky DrugStores Co., Ltd. to Report Q3, 2024 Results on Apr 25, 2024

First half dividend of JP¥12.50 announced

Second quarter 2024 earnings released: EPS: JP¥108 (vs JP¥77.00 in 2Q 2023)

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2024

New minor risk - Share price stability

Upcoming dividend of JP¥12.50 per share at 0.5% yield

Genky DrugStores Co., Ltd. to Report Q2, 2024 Results on Jan 29, 2024

First quarter 2024 earnings released: EPS: JP¥95.08 (vs JP¥72.58 in 1Q 2023)

Genky Drugstores Co., Ltd. Provides Dividend Guidance for Second Quarter and Full Year of Year Ending June 20, 2024

Genky DrugStores Co., Ltd. to Report Q1, 2024 Results on Oct 30, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Genky DrugStores Co., Ltd., Annual General Meeting, Sep 07, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Upcoming dividend of JP¥12.50 per share at 0.6% yield

Genky DrugStores Co., Ltd. to Report Fiscal Year 2023 Results on Jul 24, 2023

Third quarter 2023 earnings released: EPS: JP¥68.63 (vs JP¥61.46 in 3Q 2022)

Price target increased by 9.3% to JP¥4,700

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending June 20, 2023

Second quarter 2023 earnings released: EPS: JP¥77.00 (vs JP¥59.30 in 2Q 2022)

Genky DrugStores Co., Ltd. to Report Q2, 2023 Results on Jan 31, 2023

Upcoming dividend of JP¥12.50 per share

Less than half of directors are independent

First quarter 2023 earnings released: EPS: JP¥72.58 (vs JP¥81.18 in 1Q 2022)

Genky DrugStores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending June 20, 2023 and Full Year Ending June 20, 2023

Genky DrugStores Co., Ltd. to Report Q1, 2023 Results on Oct 24, 2022

Consensus EPS estimates fall by 12%

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Genky Drugstores Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending June 20, 2023

Genky DrugStores Co., Ltd. to Report Fiscal Year 2022 Results on Jul 26, 2022

Upcoming dividend of JP¥12.50 per share

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to JP¥5,700

Less than half of directors are independent

Genky DrugStores Co., Ltd. to Report Q3, 2022 Results on Apr 26, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Genky Drugstores Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Upcoming dividend of JP¥12.50 per share

First quarter 2022 earnings released: EPS JP¥81.18 (vs JP¥84.86 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥318 (vs JP¥182 in FY 2020)

Upcoming dividend of JP¥12.50 per share

Third quarter 2021 earnings released: EPS JP¥64.31 (vs JP¥64.70 in 3Q 2020)

Genky DrugStores Co., Ltd. to Report Q3, 2021 Results on Apr 20, 2021

New 90-day low: JP¥3,720

New 90-day low: JP¥3,795

Second quarter 2021 earnings released: EPS JP¥75.64

Upcoming Dividend of JP¥12.50 Per Share

Genky DrugStores Co., Ltd. to Report Q2, 2021 Results on Jan 20, 2021

Genky DrugStores Co., Ltd. to Report Q1, 2021 Results on Oct 20, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘